Market revenue in 2020 | USD 136.3 million |
Market revenue in 2028 | USD 311.8 million |
Growth rate | 10.9% (CAGR from 2020 to 2028) |
Largest segment | Topical |
Fastest growing segment | Oral |
Historical data | 2017 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Topical, Injectable, Oral |
Key market players worldwide | Pfizer Inc, Sanofi SA, AbbVie Inc, Galderma Group AG Registered Shares, Eli Lilly and Co, Regeneron Pharmaceuticals Inc, Otsuka Holdings Co Ltd, Novartis AG ADR, Incyte Corp, LEO Pharma |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to atopic dermatitis drugs market will help companies and investors design strategic landscapes.
Topical was the largest segment with a revenue share of 36.46% in 2020. Horizon Databook has segmented the Brazil atopic dermatitis drugs market based on topical, injectable, oral covering the revenue growth of each sub-segment from 2017 to 2028.
Healthcare reforms such as Unified Health System (SUS) provide free healthcare services to individuals at all levels without charging an additional amount. SUS is a combination of public, private, and supplemental healthcare services. Brazil is expected to hold strong opportunities for atopic dermatitis drugs market growth owing to increased accessibility of treatments.
The lifetime prevalence of atopic dermatitis in Brazil is 14%. Furthermore, for patients with the severe form of the disease psychological assessments are conducted once a year. Furthermore, according to a study conducted by Pfizer and International Alliance for Dermatology Patient Organization in 2018, Brazil performed moderately in management of atopic dermatitis.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil atopic dermatitis drugs market , including forecasts for subscribers. This country databook contains high-level insights into Brazil atopic dermatitis drugs market from 2017 to 2028, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account